Skip to main content
Kathleen Dungan, MD, Endocrinology, Columbus, OH

Kathleen M Dungan MD

Diabetes, Lipid Metabolism


Professor of Medicine, Ohio State University

Join to View Full Profile
  • 543 Taylor Ave2nd FloorColumbus, OH 43203

  • Phone+1 614-685-3333

  • Fax+1 614-366-0345

Dr. Dungan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Kathleen Dungan is an endocrinologist in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center, James Cancer Hospital and Solove Research Institute, and Chillicothe Veterans Affairs Medical Center. She received her medical degree from Ohio State University College of Medicine and has been in practice 16 years. She specializes in diabetes and lipid metabolism.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2006
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine, 2001 - 2004
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2001

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2006 - 2027
  • NC State Medical License
    NC State Medical License 2001 - 2006
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • A Comparison of Continuous Intravenous Insulin and Subcutaneous Insulin among Patients with Type 2 Diabetes and Congestive Heart Failure Exacerbation 
    Columbus, OH - 6/16/2014

Press Mentions

  • GLP-1 Drug Shortages: How Do They Affect Patients with Diabetes?
    GLP-1 Drug Shortages: How Do They Affect Patients with Diabetes?November 8th, 2024
  • Ozempic and Wegovy May Aid Anti-Cancer ‘Natural Killer’ Cells
    Ozempic and Wegovy May Aid Anti-Cancer ‘Natural Killer’ CellsMay 16th, 2023
  • Diabetes Drugs May Help Reduce Risk of Cardiovascular Events in Older Adults
    Diabetes Drugs May Help Reduce Risk of Cardiovascular Events in Older AdultsMay 8th, 2023
  • Join now to see all

Grant Support

  • Intensive Glycemic Control For Congestive Heart Failure ExacerbationNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
  • Glycemic Control And Variability In Congestive Heart Failure ExacerbationNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: